|
LRP6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.29109986327592E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.70969962818435E-11 |
| Normal-vs-Stage2 |
2.16570000044491E-07 |
| Normal-vs-Stage3 |
6.448200E-04 |
| Normal-vs-Stage4 |
4.980800E-01 |
| Stage1-vs-Stage2 |
7.583200E-01 |
| Stage1-vs-Stage3 |
3.859600E-02 |
| Stage1-vs-Stage4 |
1.655640E-01 |
| Stage2-vs-Stage3 |
1.931170E-01 |
| Stage2-vs-Stage4 |
2.070200E-01 |
| Stage3-vs-Stage4 |
4.813400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.59490001603058E-10 |
| Normal-vs-AfricanAmerican |
2.02880000021999E-07 |
| Normal-vs-Asian |
5.364800E-03 |
| Caucasian-vs-AfricanAmerican |
5.856000E-01 |
| Caucasian-vs-Asian |
8.134400E-01 |
| AfricanAmerican-vs-Asian |
9.661000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6796564139554E-12 |
| Normal-vs-Female |
2.563500E-03 |
| Male-vs-Female |
1.612160E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.97850000005495E-06 |
| Normal-vs-Extreme_Weight |
7.42794714625461E-12 |
| Normal-vs-Obese |
4.72410000007528E-07 |
| Normal-vs-Extreme_Obese |
9.00450000007602E-07 |
| Normal_Weight-vs-Extreme_Weight |
1.603580E-01 |
| Normal_Weight-vs-Obese |
5.847600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.817800E-01 |
| Extreme_Weight-vs-Obese |
2.040200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.966600E-01 |
| Obese-vs-Extreme_Obese |
2.278800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.606200E-02 |
| Normal-vs-Age(41-60Yrs) |
7.9120999996185E-07 |
| Normal-vs-Age(61-80Yrs) |
3.5527136788005E-15 |
| Normal-vs-Age(81-100Yrs) |
6.95620000046304E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.874800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.605200E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.962400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.024390E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.660840E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.325200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.71662684067542E-12 |
| Normal-VS-Type2 PRCC |
8.25960000394588E-09 |
| Normal-VS-KIRP CIMP |
8.957000E-01 |
| Normal-VS-Unclassified PRCC |
4.121000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.193400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.270100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.340300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.640200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.705200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.620210E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.48949963474365E-10 |
| Normal-vs-N1 |
3.616000E-01 |
| Normal-vs-N2 |
6.146400E-01 |
| N0-vs-N1 |
4.499500E-03 |
| N0-vs-N2 |
1.622590E-01 |
| N1-vs-N2 |
3.064200E-01 |
|
|
